EODData

MEMBERSHIP REGISTER LOG IN

FRA, L1PA: LEE S PHARMACEUTIC.HD-05

06 Nov 2025
LAST:

0.1990

CHANGE:
 0.00		OPEN:
0.1990		HIGH:
0.1990		ASK:
0.0000		VOLUME:
0
CHG(%):
0.51		PREV:
0.1980		LOW:
0.1990		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
06 Nov 250.19900.19900.19900.19900
05 Nov 250.19800.19800.19800.19800
04 Nov 250.20000.20000.20000.20000
31 Oct 250.20600.20600.20600.20609.4K
30 Oct 250.19600.19600.18600.18609.4K
29 Oct 250.19500.19500.19500.19509.4K
28 Oct 250.19800.19800.19800.19809.4K
27 Oct 250.20600.20600.19800.19809.4K
24 Oct 250.20400.20400.20400.20409.4K
23 Oct 250.20800.20800.20600.20609.4K

COMPANY PROFILE

Name:LEE S PHARMACEUTIC.HD-05
About:Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. It focuses on various disease areas, such as cardiovascular, woman's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. It operates in Proprietary and Generic Products; and Licensed-In Products segments. The Proprietary and Generic Products segment manufactures and sells Nadroparin Calcium injection and Livaracine to treat blood clots and deep vein thrombosis; Yallaferon for viral infection; Slounase for hemostasis; Socazolimab Injection for Recurrent or metastatic cervical cancer; Treprostinil injection for pulmonary arterial hypertension; fondaparinux sodium injection for deep vein thrombosis; and Sodium Phenylbutyrate Granules to treat urea cycle disorders; Apremilast Tablets for Plaque psoriasis; and Azilsartan Tablets for hypertension. The Licensed-In Products segment offers Sancuso for chemotherapy induced nausea and vomiting; Bredinin to treat Immunosuppression in renal transplantation; Centraxal Plus for acute otitis media with tympanostomy tubes; and Ferplex to treat iron deficiency anemia. This segment also offers Intrarosa for vulvovaginal atrophy; Adasuve for agitation associated with schizophrenia or bipolar I disorder in adults; Mictonorm for urinary incontinence; Natulan for Stage III and IV Hodgkin's disease; Lutrate for Prostate cancer; Nitric Oxide for Inhalation for Hypoxic respiratory failure associated with pulmonary hypertension; Omacor to treat Omega-3-acid ethyl esters; Zanidip for hypertension; Readyfusor for post-operative pain management; Teglutik to treat Amyotrophic lateral sclerosis; Trittico for insomnia/depression; Dicoflor and VSL#3 for probiotics; and Zingo for topical local analgesics. The company was founded in 1994 and is headquartered in Shatin, Hong Kong.
Sector:Healthcare
Address:Building 20E, Shatin, Hong Kong
Website:https://www.leespharm.com
ISIN:KYG5438W1116

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:10.20 
Price to Sales:0.08 
Price to Book:0.06 
Profit Margin:0.07 
Operating Margin:0.10 
Return on Assets:0.03 
Return on Equity:0.04 
DivYield:0.19 
Div/Share:0.05 
Revenue:160.41M 
EBITDA:31.92M 
Shares:588.84M 
Market Cap:117.18M 

TECHNICAL INDICATORS

MA5:0.200.6%
MA10:0.200.0%
MA20:0.215.0%
MA50:0.2210.9%
MA100:0.201.9%
MA200:0.1716.2%
STO9:65.00
STO14:38.24
RSI14:41.33
WPR14:-56.67
MTM14:-0.02
ROC14:-0.07 
ATR:0.01 
Week High:0.213.5%
Week Low:0.197.0%
Month High:0.2527.6%
Month Low:0.1916.2%
Year High:0.2733.7%
Year Low:0.1351.9%
Volatility:21.33 

RECENT DIVIDENDS

Date Amount
12 Sep 2025$0.00
28 May 2025$0.00
12 Sep 2024$0.00
28 May 2024$0.00
12 Sep 2023$0.00
25 May 2023$0.00
08 Sep 2022$0.00
26 May 2022$0.00
15 Sep 2021$0.00
31 May 2021$0.00